Johnson & Johnson - Bio, News, Photos - Washington Times
Skip to content

Johnson & Johnson

Latest Stories

earns_johnson_johnson_24300.jpg

earns_johnson_johnson_24300.jpg

FILE - In this Tuesday, Sept. 13, 2016, file photo, a selection of Johnson & Johnson brand first aid products are shown in Surfside, Fla. Johnson & Johnson reports financial earnings Tuesday, July 18, 2017. (AP Photo/Wilfredo Lee, File)

earns_johnson_johnson_01524.jpg

earns_johnson_johnson_01524.jpg

FILE - This Tuesday, Sept. 13, 2016, file photo, shows Johnson & Johnson Band-Aid brand bandages in Surfside, Fla. Johnson & Johnson reports financial earnings Tuesday, July 18, 2017. (AP Photo/Wilfredo Lee, File)

fda-psoriasis_drug_50474.jpg

fda-psoriasis_drug_50474.jpg

This photo provided by Janssen Biotech, Inc. shows the drug Tremfya. On Thursday, July 13, 2017, the Food and Drug Administration approved the new drug Tremfya, from Johnson & Johnson, for people with moderate to severe plaque psoriasis. (Janssen Biotech, Inc. via AP)

australia_pelvic_mesh_lawsuit_27637.jpg

australia_pelvic_mesh_lawsuit_27637.jpg

Members of the class action against Johnson & Johnson, Gai Thompson, left, Joanne Maninon, center, and Carina Anderson, right, arrive to address the media outside the Federal Court in Sydney on Tuesday, July 4, 2017. More than 700 Australian women have joined a class-action lawsuit against Johnson & Johnson over the pharmaceutical giant's vaginal mesh implants. (Paul Miller/AAP Image via AP)

med--johnson_and_johnson_settlement_06615.jpg

med--johnson_and_johnson_settlement_06615.jpg

FILE - In this June 30, 2009, file photo, Tylenol Extra Strength is shown in a medicine cabinet at a home in Palo Alto, Calif. In a settlement announced Wednesday, May 24, 2017, Johnson & Johnson reached a $33 million settlement with 42 states, resolving allegations the health care giant sold numerous nonprescription medicines that didn’t meet federal quality requirements for a couple of years. The case dates to 2009, when Johnson & Johnson began dozens of voluntary recalls of popular over-the-counter medicines for children and adults, including Tylenol, Motrin and Benadryl. (AP Photo/Paul Sakuma, file)

earns_johnson_johnson_68117.jpg

earns_johnson_johnson_68117.jpg

In this Tuesday, Sept. 13, 2016, photo, a selection of Johnson & Johnson brand first aid products are shown in Surfside, Fla. Johnson & Johnson reports financial earnings Tuesday, April 18, 2017. (AP Photo/Wilfredo Lee)

drugmakers-pricing_strategy_88720.jpg

drugmakers-pricing_strategy_88720.jpg

FILE - In this July 30, 2013, file photo, people walk along a corridor at the headquarters of Johnson & Johnson in New Brunswick, N.J. Several big drugmakers are trying to quell the ongoing furor over high drug prices by revealing more information about their pricing and even pledging to keep a lid on increases. The latest drugmaker move came Monday, Feb. 27, 2017, when Johnson & Johnson, the world's biggest maker of health care products, issued its first public report on price increases for its drugs. (AP Photo/Mel Evans, File)

johnson_johnson-actelion_30426.jpg

johnson_johnson-actelion_30426.jpg

FILE - This Friday, Oct. 10, 2008, file photo illustration shows Johnson & Johnson products, in Philadelphia. In a deal announced Thursday, Jan. 26, 2017, Johnson & Johnson is buying Swiss pharmaceutical Actelion in a $30 billion deal that will boost its treatments for life-threatening high blood pressure conditions. (AP Photo/Matt Rourke, File)

johnson_johnson-actelion_52638.jpg

johnson_johnson-actelion_52638.jpg

FILE - In this July 30, 2013, file photo, large banners hang in an atrium at the headquarters of Johnson & Johnson in New Brunswick, N.J. In a deal announced Thursday, Jan. 26, 2017, Johnson & Johnson is buying Swiss pharmaceutical Actelion in a $30 billion deal that will boost its treatments for life-threatening high blood pressure conditions. (AP Photo/Mel Evans, File)

johnson_johnson_acquisition.jpeg

johnson_johnson_acquisition.jpeg

In this July 30, 2013, file photo, people walk along a corridor at the headquarters of Johnson & Johnson in New Brunswick, N.J. (AP Photo/Mel Evans, File)

earns_johnson_johnson.jpeg

earns_johnson_johnson.jpeg

FILE - In this Monday, July 16, 2012, file photo, Johnson & Johnson products are displayed in Orlando, Fla. Johnson & Johnson's reports quarterly financial results, Tuesday, Jan. 26, 2016. (AP Photo/John Raoux, File)

af649778cb966b0e510f6a706700d6e8.jpg

af649778cb966b0e510f6a706700d6e8.jpg

This Oct. 16 2012 photo shows Johnson and Johnson products, including Band Aid brand adhesive bandages, arranged for a photo in St. Petersburg, Fla. Johnson & Johnson reports quarterly financial results before the market opens on Tuesday, April 15, 2014. (AP Photo/Chris O'Meara)

434012ceb03e090c500f6a7067001f3e.jpg

434012ceb03e090c500f6a7067001f3e.jpg

FILE - In this Tuesday, July 30, 2013, file photo, large banners hang in an atrium at the headquarters of Johnson & Johnson in New Brunswick, N.J. Johnson & Johnson has accepted an offer of about $4 billion from the private equity firm The Carlyle Group to buy its Ortho-Clinical Diagnostics business the company said Monday, March 31, 2014, that the deal for the blood-testing unit should close by mid-year. (AP Photo/Mel Evans, File)

adda4fbc2c51b7094d0f6a7067006cca.jpg

adda4fbc2c51b7094d0f6a7067006cca.jpg

Montana Attorney General Tim Fox announces a $5.9 million legal settlement with subsidiaries of Johnson & Johnson in Helena, Mont., on Thursday, March 6, 2014. The state's lawsuit claimed Janssen Ortho LLC and Janssen Pharmaceuticals hid the dangers of the antipsychotic drug Risperdal and promoted it for uses not approved by the Food and Drug Administration. (AP Photo/Matt Volz)